GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication Stress

Mary M. Mullen, Elena Lomonosova, Michael D. Toboni, Alyssa Oplt, Emily Cybulla, Barbara Blachut, Peinan Zhao, Hollie Noia, Daniel Wilke, Erinn B. Rankin, Lindsay M. Kuroki, Andrea R. Hagemann, Ian S. Hagemann, Carolyn K. McCourt, Premal H. Thaker, David G. Mutch, Matthew A. Powell, Nima Mosammaparast, Alessandro Vindigni and Katherine C. Fuh

Mol Cancer Res February 1 2022 (20) (2) 265-279; DOI: 10.1158/1541-7786.MCR-21-0302